Highlights
NASDAQ: DVAX       Dynavax Technologies
Last Price Today's Change   Day's Range   Trading Volume
8.67   +0.36 (4.33%)  8.07 - 9.00  4,324,700

Overview

 
Avg Volume (4 weeks):6,717,663
4 Weeks Range:5.38 - 9.74
4 Weeks Price Volatility (%):
75.46%
52 Weeks Range:1.80 - 9.74
52 Weeks Price Volatility (%):
86.52%
Average Price Target: 5.00
Price Target Upside/Downside: -3.67

Headlines



No recent Headlines for this stock.


Business Background

Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. It's current product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. Dynavax operates in the business segment the discovery and development of biopharmaceutical products. Its Toll-like Receptor Immune Modulation Platform technology play a vital role in innate immunity and subsequent adaptive immunity. Signaling through these receptors is triggered by the binding of a variety of pathogen-associated molecules and is essential to the generation of innate immunity.

  pacomax likes this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2452  5804  513  138 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ZOM 0.168-0.057 
 GNUS 3.55+1.24 
 NIO 9.38+1.47 
 LK 1.38-1.62 
 SOLO 3.13+0.80 
 WKHS 20.91+1.73 
 AAL 12.50-0.31 
 JOB 1.50+0.986 
 SQQQ 7.14-0.15 
 GE 6.82+0.08 
Partners & Brokers